Facebook Inc (NASDAQ:FB) spiked 1.03% in pre-market trading up to $95.
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, today announced that it has entered …
American billionaire Seth Klarman is the founder of the Baupost Group, the world’s 11th largest hedge fund. Klarman’s portfolio is valued at $6 …
In a research report issued Friday, J.P.
Analysts are weighing in on two biotechnology companies Keryx Pharmaceutical (NASDAQ:KERX) and Conatus Pharmaceuticals Inc (NASDAQ:CNAT), with mixed ratings. Keryx Pharmaceutical BTIG analyst Hartaj Singh came out with a …
BTIG analyst Hartaj Singh weighed in today with a pessimistic view on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company announced that its lead candidate Aurxyia (Fexeric in the …
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX), while reducing the …
Keryx Biopharmaceuticals (NASDAQ:KERX) rose more than 12% in pre-market trading up to $4.40 after this morning’s announcement that the company received approval in Europe …
Keryx Biopharmaceuticals (NASDAQ:KERX) announced that the European Commission has approved Fexeric® (ferric citrate coordination complex) for the control of elevated serum phosphorus levels, or …
In a research report published Friday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX) with a $22 …
